Ignite Creation Date:
2024-05-05 @ 11:59 AM
Last Modification Date:
2024-10-26 @ 9:18 AM
Study NCT ID:
NCT00209989
Status:
COMPLETED
Last Update Posted:
2011-11-24
First Post:
2005-09-13
Brief Title:
Phase II Trial to Assess the Radiosensitizing Effect of ZARNESTRA in Patients With Glioblastoma Multiforme
Sponsor:
Institut Claudius Regaud
Organization:
Institut Claudius Regaud
Organization Data
Organization:
Institut Claudius Regaud
Class:
OTHER
Study ID:
02 TETE 02
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Institut Claudius Regaud
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Janssen-Cilag Ltd | INDUSTRY |